Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 14, 2020 - Issue
Submit an article Journal homepage
76
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Optimization of a Benzothiazole Indolene Scaffold Targeting Bacterial Cell Wall Assembly

Jay Chauhan1 Institute of Human Virology & Department of Biochemistry and Molecular Biology of the University of Maryland Baltimore School of Medicine, Baltimore, MD 21201, USA
,
Wenbo Yu2 Computer-Aided Drug Design Center, University of Maryland, School of Pharmacy, Baltimore, MD 21201, USAORCID Iconhttps://orcid.org/0000-0001-6962-5314
ORCID Icon,
Steven Cardinale3 Microbiotix, LLC., Worcester, MA 01605, USA
,
Timothy J Opperman3 Microbiotix, LLC., Worcester, MA 01605, USA
,
Alexander D MacKerell Jr2 Computer-Aided Drug Design Center, University of Maryland, School of Pharmacy, Baltimore, MD 21201, USA;4 Department of Pharmaceutical Sciences, University of Maryland, School of Pharmacy, Baltimore, MD 21201, USA
,
Steven Fletcher1 Institute of Human Virology & Department of Biochemistry and Molecular Biology of the University of Maryland Baltimore School of Medicine, Baltimore, MD 21201, USA
&
Erik PH de Leeuw1 Institute of Human Virology & Department of Biochemistry and Molecular Biology of the University of Maryland Baltimore School of Medicine, Baltimore, MD 21201, USACorrespondence[email protected]
 show all
Pages 567-574 | Published online: 10 Feb 2020

References

  • WalshC. Where will new antibiotics come from? Nat Rev Microbiol. 2003;1(1):65–70. doi:10.1038/nrmicro72715040181
  • BreukinkE, de KruijffB. Lipid II as a target for antibiotics. Nat Rev Drug Discov. 2006;5(4):321–332. doi:10.1038/nrd200416531990
  • KochAL. Bacterial wall as target for attack: past, present, and future research. Clin Microbiol Rev. 2003;16(4):673–687. doi:10.1128/CMR.16.4.673-687.200314557293
  • SchneiderT, SahlHG. Lipid II and other bactoprenol-bound cell wall precursors as drug targets. Curr Opin Investig Drugs. 2010;11(2):157–164.
  • van HeijenoortJ. Lipid intermediates in the biosynthesis of bacterial peptidoglycan. Microbiol Mol Biol Rev. 2007;71(4):620–635. doi:10.1128/MMBR.00016-0718063720
  • HsuST, BreukinkE, TischenkoE, et al. The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics. Nat Struct Mol Biol. 2004;11(10):963–967. doi:10.1038/nsmb83015361862
  • MullerA, UlmH, Reder-ChristK, SahlHG, SchneiderT. Interaction of type A lantibiotics with undecaprenol-bound cell envelope precursors. Microb Drug Resist. 2012;18(3):261–270. doi:10.1089/mdr.2011.024222432708
  • SchneiderT, KruseT, WimmerR, et al. Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II. Science. 2010;328(5982):1168–1172. doi:10.1126/science.118572320508130
  • de LeeuwE, LiC, ZengP, et al. Functional interaction of human neutrophil peptide-1 with the cell wall precursor lipid II. FEBS Lett. 2010;584(8):1543–1548. doi:10.1016/j.febslet.2010.03.00420214904
  • VarneyKM, BonvinAM, PazgierM, et al. Turning defense into offense: defensin mimetics as novel antibiotics targeting lipid II. PLoS Pathog. 2013;9(11):e1003732. doi:10.1371/journal.ppat.100373224244161
  • BrooksBR, BrooksCL 3rd, MacKerellAD Jr., et al. CHARMM: the biomolecular simulation program. J Comput Chem. 2009;30(10):1545–1614.19444816
  • KlaudaJB, VenableRM, FreitesJA, et al. Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types. J Phys Chem B. 2010;114(23):7830–7843. doi:10.1021/jp101759q20496934
  • MacKerellAD Jr., BashfordD, BellottM, et al. All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B. 1998;102:3586–3616. doi:10.1021/jp973084f24889800
  • BestRB, ZhuX, ShimJ, et al. Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone φ, ψ and side-chain χ1 and χ2 dihedral angles. J Chem Theory Comp. 2012;8:3257–3273. doi:10.1021/ct300400x
  • JorgensenWL. Transferable intermolecular potential functions for waters, alcohols, and ethers. application to liquid water. J Am Chem Soc. 1981;103:335. doi:10.1021/ja00392a016
  • VanommeslaegheK, HatcherE, AcharyaC, et al. CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J Comp Chem. 2010;31(4):671–690.19575467
  • VanommeslaegheK, MackerellAD Jr. Automation of the CHARMM General Force Field (CGenFF) I: bond perception and atom typing. J Chem Inf Model. 2012;52(12):3144–3154. doi:10.1021/ci300363c23146088
  • VanommeslaegheK, RamanEP, MacKerellAD Jr. Automation of the CHARMM General Force Field (CGenFF) II: assignment of bonded parameters and partial atomic charges. J Chem Inf Model. 2012;52(12):3155–3168. doi:10.1021/ci300364923145473
  • ÅqvistJ, MedinaC, SamuelssonJE. A new method for predicting binding affinity in computer-aided drug design. Protein Eng. 1994;7:385–391. doi:10.1093/protein/7.3.3858177887
  • BreukinkE, van HeusdenHE, VollmerhausPJ, et al. Lipid II is an intrinsic component of the pore induced by nisin in bacterial membranes. J Biol Chem. 2003;278(22):19898–19903. doi:10.1074/jbc.M30146320012663672
  • CLSI. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard—Eighth Edition. 2009.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.